Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women

ClinicalTrials.gov ID: NCT01816139

Public ClinicalTrials.gov record NCT01816139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of WC3011 in Postmenopausal Women

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to compare the efficacy of WC3011 with placebo vaginal gel in postmenopausal women for the relief of vaginal dryness caused by vaginal atrophy as measured by self-assessment, vaginal pH and vaginal smear.

Study identification

NCT ID
NCT01816139
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Warner Chilcott
Industry
Enrollment
576 participants

Conditions and interventions

Eligibility (public fields only)

Age range
35 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2013 (Actual)
Primary completion
Nov 19, 2013 (Actual)
Completion
Nov 19, 2013 (Actual)
Last update posted
May 9, 2022

2013

United States locations

U.S. sites
48
U.S. states
19
U.S. cities
41
Facility City State ZIP Site status
Warner Chilcott Investigational Study Site Huntsville Alabama 35801 —
Warner Chilcott Investigational Study Site Mobile Alabama 36608 —
Warner Chilcott Investigational Study Site Phoenix Arizona 85032 —
Warner Chilcott Investigational Study Site Scottsdale Arizona 85251 —
Warner Chilcott Investigational Study Site Tucson Arizona 85712 —
Warner Chilcott Investigational Study Site San Diego California 92103 —
Warner Chilcott Investigational Study Site San Diego California 92108 —
Warner Chilcott Investigational Study Site San Diego California 92123 —
Warner Chilcott Investigational Study Site New London Connecticut 06320 —
Warner Chilcott Investigational Study Site Boynton Beach Florida 33472 —
Warner Chilcott Investigational Study Site Clearwater Florida 33759 —
Warner Chilcott Investigational Study Site Jacksonville Florida 32216 —
Warner Chilcott Investigational Study Site Miami Florida 33143 —
Warner Chilcott Investigational Study Site Miami Florida 33186 —
Warner Chilcott Investigational Study Site Ormond Beach Florida 32174 —
Warner Chilcott Investigational Study Site Palm Beach Gardens Florida 33410 —
Warner Chilcott Investigational Study Site Pinellas Park Florida 33781 —
Warner Chilcott Investigational Study Site West Palm Beach Florida 33409 —
Warner Chilcott Investigational Study Site Atlanta Georgia 30328 —
Warner Chilcott Investigational Study Site Roswell Georgia 30075 —
Warner Chilcott Investigational Study Site Savannah Georgia 31406 —
Warner Chilcott Investigational Study Site Granger Indiana 46530 —
Warner Chilcott Investigational Study Site Marrero Louisiana 70072 —
Warner Chilcott Investigational Study Site New Orleans Louisiana 70115 —
Warner Chilcott Investigational Study Site Kalamazoo Michigan 49009 —
Warner Chilcott Investigational Study Site Las Vegas Nevada 89106 —
Warner Chilcott Investigational Study Site Las Vegas Nevada 89113 —
Warner Chilcott Investigational Study Site Moorestown New Jersey 08057 —
Warner Chilcott Investigational Study Site Greensboro North Carolina 27408 —
Warner Chilcott Investigational Study Site New Bern North Carolina 28562 —
Warner Chilcott Investigational Study Site Winston-Salem North Carolina 27103 —
Warner Chilcott Investigational Study Site Cleveland Ohio 44122 —
Warner Chilcott Investigational Study Site Columbus Ohio 43213 —
Warner Chilcott Investigational Study Site Jenkintown Pennsylvania 19046 —
Warner Chilcott Investigational Study Site Philadelphia Pennsylvania 19114 —
Warner Chilcott Investigational Study Site Pittsburgh Pennsylvania 15206 —
Warner Chilcott Investigational Study Site Bluffton South Carolina 29910 —
Warner Chilcott Investigational Study Site Dallas Texas 75230 —
Warner Chilcott Investigational Study Site Dallas Texas 75231 —
Warner Chilcott Investigational Study Site Dallas Texas 75234 —
Warner Chilcott Investigational Study Site Houston Texas 77030 —
Warner Chilcott Investigational Study Site San Antonio Texas 78229 —
Warner Chilcott Investigational Study Site Salt Lake City Utah 84109 —
Warner Chilcott Investigational Study Site Salt Lake City Utah 84121 —
Warner Chilcott Investigational Study Site Norfolk Virginia 23507 —
Warner Chilcott Investigational Study Site Richmond Virginia 23233 —
Warner Chilcott Investigational Study Site Seattle Washington 98105 —
Warner Chilcott Investigational Study Site Spokane Washington 99207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01816139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01816139 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →